mdh.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Managing the development of a functional layout in the pharmaceutical industry
Mälardalen University, School of Innovation, Design and Engineering.
2016 (English)Independent thesis Advanced level (degree of Master (Two Years)), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

Laws and regulations are controlling and have generated great impact on the pharmaceutical industry and putting high requirements on production to follow good manufacturing procedures. There is a high pressure on production to decrease the time-to-volume for new products implementations due to the long product development phases where the medicine product patent life only have 35-40% left when production can start. This have generated that production have applied a way of thinking when developing production lines that have a tendency of becoming a scale up over time where a new production line is added to the production plant to be able to produce the volume needed for customers. Astra Zeneca, one of the largest pharmaceutical companies in the world, predicts a future where they will need to handle more products launches parallel where the new product will be produced both in small and large volumes to new customers.

In this thesis a single case study have been performed at where a new product is being implemented, the project Genuair at Astra Zeneca Sweden operations in Södertälje. This thesis have be executing with the overall aim of supporting the development of a new layout, a functional layout. The project Genuair is a project where a new product is introduced in a new way, by buying a patent. The project is in the beginning of building the first production line that have a continuous flow layout and there is already a plan to build a second production line to be able to produce the needed volume. The predicted future for the Genuair products is in line with the general predicted future within Astra Zeneca generating a need for higher volume flexibility and higher product-mix flexibility. This change will have an impact on the current Genuair production layout generating a decreasing of 45 % in volume output after analyzing the production line by building a simulation model. The current production layout is facing different limitations where long complex changeovers is the main reason for the decreasing in volume output. The current layout is also generating limitations where production is limited by equipment, vulnerable for shutdowns, laws and regulations and the need for fulfilling the capabilities of safety, health and environment, quality, deliverability and cost.

A functional layout is presented that builds on achieving volume flexibility, product-mix flexibility and expansion flexibility. The introduction of a functional layout will generate challenges within the areas of laws and regulations, compliance, location of machines in different hygiene zones, traceability, material handling, the product-process matrix and the mind set within Astra Zeneca. The functional layout is analyzed by the development of a simulation model and compared to the current production layout and proven to handle the predicted future by primarily handling the changeovers in a different way that is the main limitation that follows by having a need for high volume flexibility and product-mix flexibility within the pharmaceutical industry. The functional layout will generate a higher degree of flexibility that will come to the expense of cost.

Place, publisher, year, edition, pages
2016. , p. 103
Keywords [en]
Pharmaceutical industry, Production layout, Volume flexibility, Product-mix flexibility, Production flexibility and Production characteristics
National Category
Other Mechanical Engineering
Identifiers
URN: urn:nbn:se:mdh:diva-39788OAI: oai:DiVA.org:mdh-39788DiVA, id: diva2:1217399
External cooperation
AstraZeneca
Subject / course
Product and Process Development
Supervisors
Examiners
Available from: 2018-06-13 Created: 2018-06-13 Last updated: 2018-06-13Bibliographically approved

Open Access in DiVA

fulltext(2225 kB)52 downloads
File information
File name FULLTEXT01.pdfFile size 2225 kBChecksum SHA-512
f312b4c5a52fd7e5a5f8b5ab82a6a1c10d2d23b51950ef1ed21ed63597b58a7e4f77aa08d4869be2e108617af81e30301f1697f30017f7e61b18ca1bcda98ee6
Type fulltextMimetype application/pdf

Search in DiVA

By author/editor
Högman, Fredrik
By organisation
School of Innovation, Design and Engineering
Other Mechanical Engineering

Search outside of DiVA

GoogleGoogle Scholar
Total: 52 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
Total: 12 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf